[1] Shaw RE, Johnson CK, Ferrari G et al. Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients[J]. Transfusion, 2014, 54(4): 1106-1113. [2] Pang QY, An R, Liu HL.Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta-analysis[J]. World J Surg Oncol, 2019, 17(1): 7. [3] Xenos ES, Vargas HD, Davenport DL.Association of bloodtransfusion and venous thromboembolism after colorectalcancer resection[J]. Thromb Res, 2012, 129(5):568-572. [4] Blajchman MA.Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet?[J]. Transfusion, 1997, 37(2): 121-125. [5] Cata JP, Wang H, Gottumukkala V, et al.Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions[J]. Br J Anaesth, 2013, 110(5): 690-701. [6] Stephenson BM.Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer[J]. Ann R Coll Surg Engl, 1993, 75(6): 451. [7] Silvis R, Steup W, Brand A et al. Protective effect of blood transfusions on postoperative recurrence of Crohn’s disease in parous women[J]. Transfusion, 1994, 34(3): 242-247. [8] Aquina CT, Blumberg N, Probst CP et al. Large variation in blood transfusion use after colorectal resection: a call to action[J]. Dis Colon Rectum, 2016, 59(5): 411-418. [9] Narasimhan V, Spychal R, Pilgrim C.Blood transfusions for emergency laparotomies in general surgery[J]. J Acute Care Surg, 2017, 7(1): 15-22. [10] Usal H, Nabagiez J, Sayad P, Ferzli GS.Cost effectiveness of routine type and screen testing before laparoscopic cholecystectomy[J]. Surg Endosc, 1999, 13(2): 146-147. [11] Ghirardo SF, Mohan I, Gomensoro A, Chorost MI.Routine preoperative typing and screening: a safeguard or a misuse of resources[J]. JSLS, 2010, 14(3): 395-398. [12] Ejaz A, Spolverato G, Kim Y et al. Identifying variations in blood use based on hemoglobin transfusion trigger and target among hepatopancreaticobiliary surgeons[J]. J Am Coll Surg, 2014, 219(2): 217-28. [13] Kim Y, Spolverato G, Lucas DJ et al. Red cell transfusion triggers and postoperative outcomes after major surgery[J]. J Gastrointest Surg, 2015, 19(11): 2062-2073. [14] Bernard AC, Davenport DL, Chang PKet al. Intraoperative transfusion of 1U to 2U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia,sepsis in general surgery patients [J]. J Am Coll Surg, 2009, 208(5): 931-939.e1-2. [15] Ikuta S, Miki C, Hatada T et al. Allogenic blood transfusion is an independent risk factor for infective complications after less invasive gastrointestinal surgery[J]. Am J Surg, 2003, 185(3): 188-193. [16] Jensen L, Hokland M, Nielsen H.A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery[J]. Br J Surg, 1996, 83(7): 973-977. [17] Vamvakas EC.Platelet transfusion and adverse outcomes[J]. Lancet, 2004, 364(9447): 1736-1738. [18] Blajchman MA.Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet?[J]. Transfusion, 1997, 37(2): 121-125. |